The Inflammation Research Association is pleased to sponsor a symposium entitled:
EMERGING THERAPEUTIC PLATFORMS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
The symposium organizers, Maud Deruaz, Heidi Feldser and Joel Tocker have assembled a diverse set of speakers representing academic and biotech/pharma organizations from the local New England Bio-ecosystem that will include topics covering basic and applied science.
REGISTRATION FEES:
$125 Current IRA Member, $175 Non-Member. Both include 2025 IRA Membership
Click HERE for meeting agenda
WHEN & WHERE:
Monday, November 4, 2024, 8:00 AM – 5:30 PM
GSK Waltham site
1000 Winter Street
Waltham, MA 02451
CONFIRMED KEYNOTE SPEAKER:
ADDITIONAL CONFIRMED SPEAKERS:
David Ciccone
Nimbus Therapeutics
Title – “HPGD Inhibition is a Potent Mechanism to Dampen the Autoimmune Response and Restore Intestinal Integrity in Inflammatory Bowel Disease”
Gabriela Dower
Mediar Therapeutics
Title – “Anti-WISP1 (MTX-463) as a Novel Potential Therapy for Idiopathic Pulmonary Fibrosis”
Chloe Jones
GSK
Title – “Leveraging Encoded Technologies for Novel Binder Discovery”
Ivan Mascanfroni
Seismic Therapeutic
Title – “The promise of machine learning: using Seismic’s IMPACT platform to design IgG cleaving enzymes for chronic treatment of autoimmune diseases”
University of Massachusetts
Title – “Exploring the Role of Scarf1 in the Pathogenesis of Autoimmunity”
Jay Rothstein
Lifordi
Title – “Targeted delivery of small molecules and nucleic acids to immune cells using ADCs”
Caroline Sokol
Harvard Medical School
Title – “A neuroimmune rheostat driving itch and allergic disease”
Nan Zheng
Nocion Therapeutics
Title – “Championing a Novel Approach to Atopic Dermatitis Therapy Through Silencing Nociceptors with Charged Sodium Channel Blockers (CSCBs)”
EXHIBITOR:
